Purchase Order 36C25725P0177

Award Date 2/20/25
Potential Completion Date 4/30/25
Potential Value $112K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Amarillo, TX 79106, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $307,603 firm fixed price delivery order contract to Panhandle Nuclear RX, LTD. of Amarillo, Texas for radiopharmaceutical products. The contract has a period of performance through January 2, 2025 and was awarded on January 3, 2024 without a set-aside designation. Panhandle Nuclear RX, LTD. will provide radiopharmaceuticals to support diagnostic imaging services for veterans...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order contract to Panhandle Nuclear RX, LTD., a for-profit limited liability partnership based in Amarillo, Texas. The $254,994.00 contract is for the provision of radiopharmaceuticals to support diagnostic imaging services for the VA's Veterans Integrated Service Network 17 (VISN 17) healthcare system. This is the latest in a series of contracts between Panhandle Nuclear RX, LTD. and...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to Panhandle Nuclear RX, LTD., a small business based in Amarillo, Texas. The contract is for the provision of radiopharmaceutical products to support diagnostic imaging services for the VA healthcare system within VISN 17. The contract has a ceiling value of $145,743.00 and is a firm fixed-price delivery order contract with a period of performance from October 1,...
This federal contract award is for the provision of radioactive pharmaceuticals to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17). The prime contractor, Panhandle Nuclear RX, LTD., was awarded a Blanket Purchase Agreement (BPA) call contract valued at $387,035.00 with a performance period from October 1, 2016 to September 30, 2018. The contract is for firm fixed-price radiopharmaceutical products to support diagnostic imaging services for veterans....
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 17 (VISN 17) awarded a Blanket Purchase Agreement (BPA) call to Panhandle Nuclear RX, LTD., a partnership registered in SAM.gov since January 2006, to provide radiopharmaceuticals in support of diagnostic imaging services. The contract has a potential value of $193,518.00 and a completion date of September 30, 2020. This award was not set aside for any socioeconomic category....
This is a federal contract award to Panhandle Nuclear RX, LTD., a for-profit partnership, by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) Veterans Integrated Service Network 17. The contract is for the provision of radioactive pharmaceuticals to support diagnostic imaging services for the VA-VHA. The contract has a potential value of $193,517.50 and is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The contract does not have a...
The Department of Veterans Affairs Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) call contract to Panhandle Nuclear RX, LTD., a for-profit organization, to provide radiopharmaceuticals to support diagnostic imaging services for the VA's Veterans Integrated Service Network 17 (VISN 17) healthcare system. The contract, valued at $206,506.45, has a firm fixed price pricing type and a period of performance through September 17, 2023. This BPA call is one of several awards...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Nuclear Diagnostic Products, Inc., a for-profit organization, on May 2, 2018. The $107,176.03 contract is for the provision of radiopharmaceuticals to support nuclear medicine imaging procedures for veterans at VA facilities in VISN 4, which covers Pennsylvania and Delaware. Nuclear Diagnostic Products, Inc. is an established prime vendor of radiopharmaceuticals to the...
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Nuclear Diagnostic Products, Inc., a for-profit organization specializing in the supply of radiopharmaceuticals. The contract, valued at $330,602.10, is for the provision of general radiopharmaceuticals to support nuclear medicine imaging procedures across the VA's Veterans Integrated Service Network (VISN) 2, which covers facilities primarily in the northeastern United States. The...
<p>This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 5 (VISN 5) of the U.S. Department of Veterans Affairs to Radiology Services of Northern Virginia LLC, a veteran-owned limited liability company. The contract is for the provision of radiopharmaceuticals, with a total ceiling value of $194,756.25 and a period of performance ending on March 31, 2025. The contract was awarded on October 1, 2024, and does not have a set-aside designation.</p>

This $111,755.00 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs' Veterans Health Administration (VHA) Veterans Integrated Service Network 17 (VISN 17) to Panhandle Nuclear RX, LTD., a for-profit company based in Amarillo, Texas. The award is for the provision of radiopharmaceuticals to support diagnostic imaging services for the VA healthcare system within VISN 17.

This purchase order is part of a larger $615,206.00 single-award Indefinite Delivery Vehicle (IDV) contract between the VHA VISN 17 and Panhandle Nuclear RX, LTD. that was awarded on January 4, 2023, with a performance period through January 3, 2025. Two firm fixed-price delivery orders, valued at $307,603.00 each, have been issued against this IDV contract. The purchase order described was awarded without any set-aside designation.

Generated 2/21/25, 9:02 AM